Cancer Pain

Latest

Updated Guideline for Palliative Radiotherapy for Bone Metastases

Updated Guideline for Palliative Radiotherapy for Bone Metastases

A guideline update from the American Society for Radiation Oncology continues to support the efficacy and safety of palliative radiation therapy for bone metastases.

Sublingual Fentanyl Preferred, But Less Effective Than Subcutaneous Morphine

Sublingual Fentanyl Preferred, But Less Effective Than Subcutaneous Morphine

Fentanyl sublingual tablets are preferred over subcutaneous morphine in patients with severe breakthrough cancer pain.

Underprescription of Opioids in Cancer Patients During End of Life

Underprescription of Opioids in Cancer Patients During End of Life

Although opioids are considered a first-line treatment for late-stage cancer pain, they are often prescribed relatively late and for only a short duration before death in many patients.

Breakthrough Cancer Pain With Lazanda at New Dosage

Breakthrough Cancer Pain With Lazanda at New Dosage

Depomed has announced that Lazanda (fentanyl) nasal spray, CII, is now available at 300mcg dose strength to treat cancer pain.

Families Prefer Hospice Over Hospital for Relatives Dying From Cancer

Families Prefer Hospice Over Hospital for Relatives Dying From Cancer

Earlier hospice enrollment important area to focus on to improve the quality of end-of-life cancer care.

Lower Hospital Costs Tied to Palliative Care Consult

Lower Hospital Costs Tied to Palliative Care Consult

Greater cost savings for cancer patients with more comorbidities.

Aspirin Use Linked to Lower Risk of Lethal Prostate Cancer, Study Shows

Aspirin Use Linked to Lower Risk of Lethal Prostate Cancer, Study Shows

Risk of prostate cancer mortality reduced with regular aspirin use after diagnosis.

New Insight on the Role of Aspirin in Breast Cancer

New Insight on the Role of Aspirin in Breast Cancer

Two new studies shed more light on whether of aspirin can help treat breast cancer patients.

Time to Treatment Initiation Impacts Survival in Head, Neck Cancer

Time to Treatment Initiation Impacts Survival in Head, Neck Cancer

Lower overall survival for time to treatment initiation of more than 46 to 52 days.

Suicide Risk Rises for Head, Neck Cancer Patients

Suicide Risk Rises for Head, Neck Cancer Patients

Dependence on breathing tubes, feeding tubes might play a part in despair.